bromodeoxyuridine has been researched along with Scleroderma, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabane, J; Chéreau, C; Dinh-Xuan, AT; Duong-Quy, S; Hua-Huy, T; Tiev, KP | 1 |
| Amblard, P; Huet-Warembourg, E; Jalbert, H; Jalbert, P; Legoff, D; Pison, H; Reymond, JL; Sele, B | 1 |
2 other study(ies) available for bromodeoxyuridine and Scleroderma, Systemic
| Article | Year |
|---|---|
Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis.
Topics: Actins; Adult; Blood Proteins; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Humans; Male; Middle Aged; Myocytes, Smooth Muscle; Nitric Oxide; Prospective Studies; Pulmonary Alveoli; Pulmonary Fibrosis; Scleroderma, Systemic; Serum | 2010 |
[Cytogenetic aspects of diffuse scleroderma : structural anomalies and sister chromatid exchanges (author's transl)].
Topics: Adult; Aged; Bromodeoxyuridine; Cell Division; Cells, Cultured; Chromosome Aberrations; Crossing Over, Genetic; Female; Humans; Lymphocytes; Male; Middle Aged; Scleroderma, Systemic; Sister Chromatid Exchange | 1982 |